참고문헌
- Park JS. Acute viral lower respiratory tract infections in children. Korean Journal of Pediatrics 2009;52:269-76. https://doi.org/10.3345/kjp.2009.52.3.269
- Jung BS, Cho B, Kim HH, Lee JS. A clinical study of respiratory tract infection. Pediatr Allergy Respir Dis (Korea). 1996;6:60-3.
- Elliot AJ, Fleming DM. Viral infections and acute otitis media in young children. Clin Infect Dis 2008;47:146-7.
- Williams JV. The clinical presentation and outcomes of children infected with newly identified respiratory tract viruses. Infect Dis Clin North Am. 2005;19:569-84. https://doi.org/10.1016/j.idc.2005.05.009
- Ogra PL. Respiratory syncytial virus: the virus, the disease and the immune response. Paediatr Respir Rev 2004;5:119-26. https://doi.org/10.1016/S1526-0542(04)90023-1
- Stensballe LG, Devasundaram JK, Simoes EA. Respiratory syncytial virus epidemics: the ups and downs of a seasonal virust . Pediatr InfecDis J 2003;21-32.
- Hahn WH, Chang JY, Bae CW. Birth statistics and mortality rates for neonatal intensive care units in Korea during 2007: collective results from 57 hospitals. J Korean Soc Neonatol 2009;16:36-46.
- Glezen WP, Taber LH, Frank AL, Kasel JA. Risk of primary infection and reinfection with respiratory syncytial virus. Am J Dis Child 1986;140:543-6.
- Garenne M, Ronsmans C, Campbell H. The magnitude of mortality from acute respiratory infections in children under 5 years in developing countries. World Health Stat Q 1992;45:180-91.
- The IMpact-RSV Study Group. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics 1998;102:531-7. https://doi.org/10.1542/peds.102.3.531
- Prais D, Schonfeld T, Amir J. Admission to the intensive care unit for respiratory syncytial virus bronchiolitis: a national survey before palivizumab use. Pediatrics 2003;112:548-52. https://doi.org/10.1542/peds.112.3.548
- Reeve CA, Whitehall JS, Buettner PG, Norton R, Reeve DM, Francis F. Cost-effectiveness of respiratory syncytial virus prophylaxis with palivizumab. J Paediatr Child Health 2006;42:253-8. https://doi.org/10.1111/j.1440-1754.2006.00850.x
- Farina D, Rodriguez SP, Bauer G, Novali L, Bouzas L, Gonzalez H, et al. Respiratory syncytial virus prophylaxis: cost-effective analysis in Argentina. Pediatr Infect Dis J 2002;21:287-91. https://doi.org/10.1097/00006454-200204000-00006
- Nuijten MJ, Wittenberg W. Cost effectiveness of palivizumab in Spain: an analysis using observational data. Eur J Health Econ 2010;11:105-15. https://doi.org/10.1007/s10198-009-0206-x
- Resch B, Gusenleitner W, Nuijten MJ, Lebmeier M, Wittenberg W. Cost-effectiveness of palivizumab against respiratory syncytial viral infection in high-risk children in Austria. Clin Ther 2008;30:749-60. https://doi.org/10.1016/j.clinthera.2008.03.014
- Lanctot KL, Masoud ST, Paes BA, Tarride JE, Chiu A, Hui C, et al. The cost-effectiveness of palivizumab for respiratory syncytial virus prophylaxis in premature infants with a gestational age of 32-35 weeks: a Canadianbased analysis. Curr Med Res Opin 2008;24:3223-37. https://doi.org/10.1185/03007990802484234
- Denny FW, Clyde WA, Jr. Acute lower respiratory tract infections in nonhospitalized children. J Pediatr 1986;108:635-46. https://doi.org/10.1016/S0022-3476(86)81034-4
- Hall CB. Respiratory syncytial virus and parainfluenza virus. N Engl J Med 2001;344:1917-28. https://doi.org/10.1056/NEJM200106213442507
- Law BJ, Langley JM, Allen U, Paes B, Lee DS, Mitchell I, et al. The pediatric investigators collaborative network on infections in Canada study of predictors of hospitalization for respiratory syncytial virus infection for infants born at 33 through 35 completed weeks of gestation. Pediatr Infect Dis J 2004;23:806-14. https://doi.org/10.1097/01.inf.0000137568.71589.bd
- Law BJ, Carbonell-Estrany X, Simoes EA. An update on respiratory syncytial virus epidemiology: a developed country perspective. Respir Med 2002;96:1-7. https://doi.org/10.1053/rmed.2001.1207
-
Tatochenko V, Uchaikin V, Gorelov A, Gudkov K, Campbell A, Schulz G, et al. Epidemiology of respiratory syncytial virus in children
${\leq}$ 2 years of age hospitalized with lower respiratory tract infections in the Russian Federation: a prospective, multicenter study. Clin Epidemiol 2010;2:221-7. - Mori M, Kawashima H, Nakamura H, Nakagawa M, Kusuda S, Saji T, et al. Nationwide survey of severe respiratory syncytial virus infection in children who do not meet indications for palivizumab in Japan. J Infect Chemother 2011;17:254-63. https://doi.org/10.1007/s10156-010-0121-1
- Fitzgerald DA. Preventing RSV bronchiolitis in vulnerable infants: the role of palivizumab. Paediatr Respir Rev 2009;10:143-7. https://doi.org/10.1016/j.prrv.2009.06.002
- The PREVENT Study Group. Reduction of respiratory syncytial virus hospitalization among premature infants and infants with bronchopulmonary dysplasia using respiratory syncytial virus immune globulin prophylaxis. Pediatrics 1997;99:93-9. https://doi.org/10.1542/peds.99.1.93
- Romero JR. Palivizumab prophylaxis of respiratory syncytial virus disease from 1998 to 2002: results from four years of palivizumab usage. Pediatr Infect Dis J 2003;22:46-54.
- American academy of pediatrics committee on infectious diseases and committee of fetus and newborn. Prevention of respiratory syncytial virus infections: indications for the use of palivizumab and update on the use of RSVIGIV. Pediatrics 1998;102:1211-6. https://doi.org/10.1542/peds.102.5.1211
- Resch B, Paes B. Are late preterm infants as susceptible to RSV infection as full term infants? Early Hum Dev 2011;87:47-9. https://doi.org/10.1016/j.earlhumdev.2011.01.010
- Lanari M, Silvestri M, Rossi GA. Palivizumab prophylaxis in 'late preterm' newborns. J Matern Fetal Neonatal Med 2010;23:53-5. https://doi.org/10.3109/14767058.2010.506757
- Figueras Aloy J, Quero J, Domenech E, Lopez Herrera MC, Izquierdo I, Losada A, et al. Recommendations for the prevention of respiratory syncytial virus infection. An Pediatr (Barc) 2005;63:357-62. https://doi.org/10.1157/13079818